ArticleJournal of Korean medical science2012

Comparison of systemic adverse events associated with intravitreal anti-VEGF injection: ranibizumab versus bevacizumab.

Duck Jin Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.